(148 days)
Not Found
No
The description focuses on standard fetal monitoring technology (ultrasound, TOCO transducer, strain gauge) and does not mention any AI or ML capabilities. The "Mentions AI, DNN, or ML" section also explicitly states "Not Found".
No
The device is a fetal monitor used for diagnostic purposes (monitoring fetal well-being and contractions), not for treating or interveining in a medical condition.
Yes
Explanation: The device monitors fetal well-being and performs a non-stress test, which involves assessing physiological parameters (fetal heart rate and maternal contractions) to evaluate the health status, indicating a diagnostic purpose.
No
The device description explicitly details hardware components such as ultrasound transducers, TOCO transducers, belts, numerical readouts, a strip chart recorder, and a manual hand-held pushbutton marker. This indicates it is a hardware-based medical device with potentially integrated software, not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Cadence Fetal Monitor Function: The Cadence Fetal Monitor is a non-invasive device that uses ultrasound and a tocotonometer to monitor fetal heart rate and maternal contractions. It does not analyze samples taken from the body.
- Method of Operation: The device works by applying transducers to the maternal abdomen to detect physiological signals (fetal heart sounds and abdominal displacement).
Therefore, the Cadence Fetal Monitor falls under the category of a medical device used for monitoring physiological parameters, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Cadence Fetal Monitor, model 2001 for singletons and model 2002 for twins, is a fetal monitor for monitoring fetal well being during the antepartum period. It performs what is commonly called the non -stress test.
Product codes (comma separated list FDA assigned to the subject device)
HGM
Device Description
The Cadence Fetal monitor is a perinatal monitoring system for non-invasively measuring, displaying and printing out in graphic form on a strip chart recorder maternal abdominal contractions and fetal heart rate for either a singleton fetus or twin fetuses during the last trimester. A manual hand held pushbutton marker for patient identification of contractions is also part of the monitor. The Cadence Fetal monitor uses one or two ultrasound transducers for monitoring the fetal heart rate (FHR) depending on whether there is a singleton or twin pregnancy. The multi crystal , broad band ultrasound transducer operates at a frequency of 2 mHz. The ultrasound transducer or transducers are placed on the maternal abdomen by means of one or two belts and transmits the ultrasound signal to the fetal heart(s). The transducer(s) also receive the echo from the fetal heart(s) and processes the echoes determining the fetal heart rate(s) The TOCO transducer is also placed on the maternal abdomen with a belt and it detects the forward displacement of the maternal abdominal muscles during a contraction. The TOCO transducer is a tocotonometer which operates on the strain gauge principle to measure displacement. The central section of the TOCO transducer is depressed by the forward displacement of the abdominal muscles during a contraction. It is used for assessing frequency and duration of uterine contractions. It gives an indication of contractions pressure.
The fetal heart rate(s) and TOCO percent contractions pressure are displayed on numerical readouts and printed out on a strip chart recorder in graphic form.
A fetal event marker pushbutton is also available for the patient to identify contractions manually by pushing the button on the fetal event marker.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Pulsed Doppler
Anatomical Site
maternal abdomen (for the fetus and maternal contractions)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained medical personnel in hospitals, clinics, physicians offices and in the patients home by prescription or doctors orders.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Cadence Fetal monitor device has been subjected to Extensive safety, performance testing, and validation before release. Final testing of the Cadence Fetal monitor included various performance tests designed to ensure that the device met all of its functional requirements and performance specifications. Safety tests have been performed to ensure the device complies with applicable industry and safety standards.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 884.2740 Perinatal monitoring system and accessories.
(a)
Identification. A perinatal monitoring system is a device used to show graphically the relationship between maternal labor and the fetal heart rate by means of combining and coordinating uterine contraction and fetal heart monitors with appropriate displays of the well-being of the fetus during pregnancy, labor, and delivery. This generic type of device may include any of the devices subject to §§ 884.2600, 884.2640, 884.2660, 884.2675, 884.2700, and 884.2720. This generic type of device may include the following accessories: Central monitoring system and remote repeaters, signal analysis and display equipment, patient and equipment supports, and component parts.(b)
Classification. Class II (performance standards).
0
CADENCE 510k SUBMISSION -
Cadence Fetal Monitor Edan Instruments, Inc.
SUMMARY
This summary of 510k safety and effectiveness information is being submitted in accordance with 21CFR part 807.92
- Submitters name, address, phone number, contact person and 1. preparation date:
Name:
Edan Instruments, Inc. 4/F, New Energy Building 2009 Nanyou Road Nanshan, Shenzhen, Guangdong 5188054 China Phone: 86 755 26062059 86 755 26062022 Fax: Responsible person: Xie Xicheng
Official Correspondent:
William Stern Multigon Industries, Inc. 1 Odell Plaza Yonkers, N.Y. 10701 Phone: 914 376 5200 X27 914 376 5565 Fax:
Date of Preparation: 4/2/04
1
040903
| 2. Device: | |||||
|---|---|---|---|---|---|
| Proprietary Name: Cadence Ante partum Fetal Monitor model 2001 (Singleton) and model 2002 (Twins) | |||||
| Common Name: Fetal Monitor | |||||
| Classification Name: 21 CFR 884.2740 System, Monitoring, Perinatal | |||||
| Product Code: HGM | |||||
| Manufactured By: Edan instruments, Inc. China | |||||
| 2. Predicate Devices: Comparison of the Cadence Fetal monitor to the Predicate Devices | |||||
| DEVICE | CADENCE 2001,2002 | SONICAID 820 | COROMETRICS 171 AND 172 | ||
| ATTRIBUTE | |||||
| 510k Number | K040903 | K002150 | K991905 | ||
| Singleton (model 2001) | yes | yes | yes | ||
| Twins (model 2002) | yes | yes | yes | ||
| Fetal Heart Detection: Pulsed Doppler With Auto-Correlation | yes | yes | yes | ||
| Fetal Heart Rate Display Units | 1 BPM | 1 BPM | 1 BPM | ||
| Fetal Heart Rate Range | 50-210 BPM | 30-240 BPM | 50-210 BPM | ||
| Ultrasound Frequency | 2 MHz | 1.5 MHz and 2.0 MHz | 1.15 MHz | ||
| Ultrasound | 6.972 ISPTA | less than 100 ISPTA | 5 ISATA |
Power (mw/sq.cm)
2
KOYO903
| Fetal Heart
| Rate Alarms | yes | yes | yes |
|---|---|---|---|
| DEVICE | CADENCE | SONICAID 820 | COROMETRICS |
| 171/172 | |||
| ATTRIBUTE | |||
| Toco | |||
| Transducer | |||
| Type | strain gauge | strain gauge | strain gauge |
| Toco Range | |||
| (relative units) | 0-100 | 0-100 | 0-100 |
| Toco Resolution | |||
| (relative units) | 1 | 1 | 1 |
| Chart Recorder | yes | yes | yes |
| Numeric Display | |||
| Of Results | yes | yes | yes |
Conclusion: The Cadence model 2001 singleton and 2002 twin monitors are Similar and equivalent to the two predicate devices , the Sonicaid 820 and the Corometrics 171/172 in principles of operation, specifications, and performance.
3. Classification Names:
Class II as per 21 CFR 884.2740 System., Monitoring,Perinatal
- Description ഗ
The Cadence Fetal monitor is a perinatal monitoring system for non-invasively measuring, displaying and printing out in graphic form on a strip chart recorder maternal
3
abdominal contractions and fetal heart rate for either a singleton fetus or twin fetuses during the last trimester. A manual hand held pushbutton marker for patient identification of contractions is also part of the monitor. The Cadence Fetal monitor uses one or two ultrasound transducers for monitoring the fetal heart rate (FHR) depending on whether there is a singleton or twin pregnancy. The multi crystal , broad band ultrasound transducer operates at a frequency of 2 mHz. The ultrasound transducer or transducers are placed on the maternal abdomen by means of one or two belts and transmits the ultrasound signal to the fetal heart(s). The transducer(s) also receive the echo from the fetal heart(s) and processes the echoes determining the fetal heart rate(s) The TOCO transducer is also placed on the maternal abdomen with a belt and it detects the forward displacement of the maternal abdominal muscles during a contraction. The TOCO transducer is a tocotonometer which operates on the strain gauge principle to measure displacement. The central section of the TOCO transducer is depressed by the forward displacement of the abdominal muscles during a contraction. It is used for assessing frequency and duration of uterine contractions. It gives an indication of contractions pressure.
The fetal heart rate(s) and TOCO percent contractions pressure are displayed on numerical readouts and printed out on a strip chart recorder in graphic form.
A fetal event marker pushbutton is also available for the patient to identify contractions manually by pushing the button on the fetal event marker.
- Indications for Use. 6.
The Cadence Fetal Monitor, model 2001 for singletons and model 2002 for twins, is a fetal monitor for monitoring fetal well being during the antepartum period. It performs what is commonly called the non -stress test.
4
k 640903
The Cadence Fetal Monitor 2001/2002 is to be used by trained medical personnel in hospitals, clinics, physicians offices and in the patients home by prescription or doctors orders. -
-
- Contra-Indications.
None known at this time
- Contra-Indications.
-
Comparison to Predicate Devices. 8.
The Cadence Fetal Monitor has the same device characteristics of all of the approved predicate devices listed in item 3 above with the commonality of ultrasound transducer(s) principles of operation, TOCO transducer principle of operation, ultrasound fetal heart detection and display, contraction detection and display and fetal event marker and display, and graphic recording and display available. -
ರು. Test Data:
The Cadence Fetal monitor device has been subjected to Extensive safety, performance testing, and validation before release. Final testing of the Cadence Fetal monitor included various performance tests designed to ensure that the device met all of its functional requirements and performance specifications. Safety tests have been performed to ensure the device complies with applicable industry and safety standards.
The Cadence fetal monitor device labeling includes instructions for safe and effective use, warnings, cautions, and guidance for use. It has been shown there fore to be safe and effective.
-
- Literature Review:
A review of the literature pertaining to the safety of the Cadence Fetal monitor has been conducted and appropriate safeguards have been incorporated in the design of the Cadence Fetal monitor.
- Literature Review:
-
- Conclusions:
The conclusion drawn from these tests is that the Cadence
- Conclusions:
5
Fetal monitor is equivalent in safety and efficacy to the predicate devices listed in # 3. above.
.
6
Image /page/6/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of an eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP - 2 2004
Edan Instruments, Inc. c/o Mr. William Stern Official Correspondent Multigon Industries, Inc. 1 Odell Plaza YONKERS NY 10701
Re: K040903
Trade/Device Name: Cadence Antepartum Fetal Monitor; Model 2001 -Cadence (singleton) and Model 2002 -- Cadence Dual (twin) Regulation Number: 21 CFR §884.2740 Regulation Name: Perinatal monitoring system and accessories Regulatory Class: II Product Code: 85 HGM Dated: August 4, 2004 Received: August 10, 2004
Dear Mr. Stern:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the Cadence Antepartum Fetal Monitor as described in your premarket notification:
Transducer Model Number
2 MHz PW Doppler Fetal Probe
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be may of cable of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish
7
Page 2 - Mr. William Stern
further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801, please r you added office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
If you have any questions regarding the content of this letter, please contact Mr. Slade Stratton at (301) 594-1212.
Sincerely yours.
David An. Syzomm
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosures
8
CADENCE MODEL 2001 CADENCE MODEL 2002 DUAL 510K SUBMISSION
Appendix F
Diagnostic Ultrasound Indications for Use Form
Fill out one form for each ultrasound system and each transducer. เกิโคที่มีสินธุรีส์ โดยสิทธิริโทรทัศน์ PROBE: - เปรีย สิทธิประเร็ง of the human body as follows:
| Mode of Operation | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Application | A | B | M | PWD | CWD | Color | ||||
| Doppler | Amplitude | |||||||||
| Doppler | Color | |||||||||
| Velocity | ||||||||||
| Imaging | Combined | |||||||||
| (specify) | Other | |||||||||
| (specify) | ||||||||||
| Ophthalmic | ||||||||||
| Fetal | N | |||||||||
| Abdominal | ||||||||||
| Intraoperative (specify) | ||||||||||
| Intraoperative Neurological | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | ||||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Cardiac | ||||||||||
| Transesophageal | ||||||||||
| Transrectal | ||||||||||
| Transvaginal | ||||||||||
| Transurethral | ||||||||||
| Intravascular | ||||||||||
| Peripheral Vascular | ||||||||||
| Laparoscopic | ||||||||||
| Musculo-skeletai | ||||||||||
| Conventional | ||||||||||
| Musculo-skeletal Superficial | ||||||||||
| Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:_The above_is_a_2 mHz Pulsed Wave Transducer for fetal heart rate detection
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Darrel R. Larson
(Division Sian-Off) Division of Reproductive, Abdom and Radiological Devic 510(k) Number
Prescription Use (Per 21 CFR 801.109)
9
CADENCE MODEL 2001 CADENCE MODEL 2002 DUAL 510K SUBMISSION
16
Indications for Use
510(k) Number (if known):
Device Name:
Fietal Monitor 2001/2002 Cadence
Indications For Use:
The Cadence Fetal Monitor , model 2001 for singletons and model 2002 for twins, is a fetal monitor for monitoring fetal well being during the antepartum period. It performs what is commonly called the non stress test.
The Cadence Fetal Monitor 2001/2002 is to be used by trained medical personnel in hospitals clinics, physicians offices, and in the patients home by prescription or doctors orders.
Prescription Use YES (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use __ No (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) 14
Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Ingram
(Division Sign-Off) Division of Reproductive, Abdomin and Radiological Dev 510(k) Number
Page 1 of 2